Structure via PubChem · Public domain (PubChem)
benzofuranylpropylaminopentane
Sign in to saveAlso known as (-)-BPAP
(–)-Benzofuranylpropylaminopentane (BPAP; developmental code name FPFS-1169) is an experimental drug related to selegiline which acts as a monoaminergic activity enhancer (MAE). It is orally active in animals.
In the Vinony graph
Within Vinony's link graph, benzofuranylpropylaminopentane is referenced by 1,050 other articles, and connects out to route of administration, monoamine oxidase inhibitor and lysergic acid diethylamide.
It is catalogued under topics including Anti-aging substances, Antidepressants and Antiparkinsonian agents.
Its subject is documented across 4 Wikipedia language editions.
Chemical data
- Formula
- C16H23NO
- Molecular weight
- 245.36 g/mol
- IUPAC name
- 1-(1-benzofuran-2-yl)-N-propylpentan-2-amine
- SMILES
- CCCC(CC1=CC2=CC=CC=C2O1)NCCC
- InChIKey
- LJHIBIVAYHQPBT-UHFFFAOYSA-N
- XLogP
- 4.4
- Polar surface area
- 25.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 245.177964356
Show 3 more facts
- chemical formula
- C₁₆H₂₃NO
- canonical SMILES
- CCCC(CC1=CC2=CC=CC=C2O1)NCCC
- Commons category
- Benzofuranylpropylaminopentane
via Wikidata · CC0
~10 min read
Encyclopedic overview
11 sectionsContents
- Pharmacology
- Pharmacodynamics
- Monoaminergic activity enhancer
- Other actions
- Pharmacokinetics
- Chemistry
- History
- Research
- See also
- References
- External links
(–)-Benzofuranylpropylaminopentane (BPAP; developmental code name FPFS-1169) is an experimental drug related to selegiline which acts as a monoaminergic activity enhancer (MAE). It is orally active in animals.
BPAP is a highly potent MAE and enhances the nerve impulse propagation-mediated release of serotonin, norepinephrine, and dopamine. At much higher concentrations, BPAP is also a monoamine reuptake inhibitor, specifically of dopamine and norepinephrine and to a much lesser extent of serotonin. BPAP produces psychostimulant-like effects in animals, with these effects mediated by its MAE actions. The drug is a substituted benzofuran derivative and tryptamine relative structurally related to phenylpropylaminopentane (PPAP).
Excerpted from Wikipedia’s “benzofuranylpropylaminopentane” article, available under the CC BY-SA 4.0 licence.